Teva Pharmaceuticals USA, Inc., v. GlaxoSmithKline, LLC
Petition for certiorari denied on May 15, 2023
Issue: Whether a generic drug manufacturer's FDA-approved label that carves out all of the language the brand manufacturer has
identified as covering its patented uses can be held liable on a theory that its label still intentionally encourages infringement of
those carved-out uses.
SCOTUSblog Coverage
- Congressional redistricting, patent infringement, arbitration, and the Armed Career Criminal Act (John Elwood, May 11, 2023)
- Court agrees to hear nine new cases, including challenge to tech companies’ immunity under Section 230 (Amy Howe, October 3, 2022)
- Justices asked to strengthen the right to earn a living (Kalvis Golde, July 29, 2022)
| Date | Proceedings and Orders (key to color coding) |
|---|
| Apr 29 2022 | Application (21A677) to extend the time to file a petition for a writ of certiorari from May 12, 2022 to July 11, 2022, submitted to The Chief Justice. |
| May 03 2022 | Application (21A677) granted by The Chief Justice extending the time to file until July 11, 2022. |
| Jul 11 2022 | Petition for a writ of certiorari filed. (Response due August 12, 2022) |
| Jul 25 2022 | Motion to extend the time to file a response from August 12, 2022 to September 12, 2022, submitted to The Clerk. |
| Jul 26 2022 | Motion to extend the time to file a response is granted and the time is extended to and including September 12, 2022. |
| Aug 10 2022 | Brief amici curiae of 42 Professors of Law, Economics, Business, and Medicine filed. |
| Aug 12 2022 | Brief amicus curiae of Alvotech filed. |
| Aug 12 2022 | Brief amicus curiae of Mylan Pharmaceuticals Inc. filed. |
| Aug 12 2022 | Brief amicus curiae of Association for Accessible Medicines filed. |
| Aug 19 2022 | Brief of respondents GlaxoSmithKline LLC, et al. in opposition filed. |
| Sep 07 2022 | DISTRIBUTED for Conference of 9/28/2022. |
| Sep 07 2022 | Reply of petitioner Teva Pharmaceuticals USA, Inc. filed. (Distributed) |
| Oct 03 2022 | The Solicitor General is invited to file a brief in this case expressing the views of the United States. |
| Mar 29 2023 | Brief amicus curiae of United States filed. |
| Apr 11 2023 | Supplemental brief of respondents GlaxoSmithKline LLC, et al. filed. (Distributed) |
| Apr 12 2023 | DISTRIBUTED for Conference of 4/28/2023. |
| May 08 2023 | DISTRIBUTED for Conference of 5/11/2023. |
| May 15 2023 | Petition DENIED. Justice Kavanaugh would grant the petition for a writ of certiorari. |
